Metabolite M6

Metabolite details

Identifier

MKMGKCALCCOODL-GVPWJHIJSA-N

InChI Key

MKMGKCALCCOODL-GVPWJHIJSA-N

IUPAC name

(2R)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-[[(1R,2S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butylpiperazine-2-carboxamide

Preferred name

Metabolite M6

INN name

—

Synonym

—

ChEBI

CHEBI:176211

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Effects of Radiofrequency Field from 5G Communications on fecal microbiome and metabolome profiles in mice
• Intergenerational Association of Gut Microbiota and Metabolism between Perinatal Folic Acid Metabolism and Neural Tube Defects (Feces metabolomics)
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage

Observed in differential profiles

• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Control_vs_nsPEF_7_day
• G1_PBS_vs_G2_DSS
• Sham_vs_Radiofrequency
• Normal_vs_Neural_Tube_Defect
• Control_vs_ZYP_High_Dose
• Control_0d_vs_Treatment_180d